Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/1/17 → 9/1/20 |
Funding
- Chiltern International, Inc. (Prot #13676-01 // Prot #13676-01)
- Xencor, Inc. (Prot #13676-01 // Prot #13676-01)
Prot #13676-01: A Phase 1 Multidose Study To Evaluate The Safety And Tolerability Of XmAb®13676 In Patients With Cd20-Expressing Hematologic Malignancies
- Karmali, Reem (PD/PI)
Project: Research project